Global Biosimilar Insulin Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilar Insulin Consumption 2016-2026

2.1.2 Biosimilar Insulin Consumption CAGR by Region

2.2 Biosimilar Insulin Segment by Type

2.2.1 Biosimilar Insulin Glargine

2.2.2 Biosimilar Insulin Lispro

2.2.3 Other

2.3 Biosimilar Insulin Sales by Type

2.3.1 Global Biosimilar Insulin Sales Market Share by Type (2016-2021)

2.3.2 Global Biosimilar Insulin Revenue and Market Share by Type (2016-2021)

2.3.3 Global Biosimilar Insulin Sale Price by Type (2016-2021)

2.4 Biosimilar Insulin Segment by Distribution Channel

2.4.1 Hospital

2.4.2 Retail Pharmacy

2.4.3 Others

2.5 Biosimilar Insulin Sales by Distribution Channel

2.5.1 Global Biosimilar Insulin Sale Market Share by Distribution Channel (2016-2021)

2.5.2 Global Biosimilar Insulin Revenue and Market Share by Distribution Channel (2016-2021)

2.5.3 Global Biosimilar Insulin Sale Price by Distribution Channel (2016-2021)

3 Global Biosimilar Insulin by Company

3.1 Global Biosimilar Insulin Sales Market Share by Company

3.1.1 Global Biosimilar Insulin Sales by Company (2019-2021)

3.1.2 Global Biosimilar Insulin Sales Market Share by Company (2019-2021)

3.2 Global Biosimilar Insulin Revenue Market Share by Company

3.2.1 Global Biosimilar Insulin Revenue by Company (2019-2021)

3.2.2 Global Biosimilar Insulin Revenue Market Share by Company (2019-2021)

3.3 Global Biosimilar Insulin Sale Price by Company

3.4 Global Manufacturers Biosimilar Insulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilar Insulin Product Location Distribution

3.4.2 Players Biosimilar Insulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Insulin by Region

4.1 Global Biosimilar Insulin by Region

4.1.1 Global Biosimilar Insulin Sales by Region

4.1.2 Global Biosimilar Insulin Revenue by Region

4.2 Americas Biosimilar Insulin Sales Growth

4.3 APAC Biosimilar Insulin Sales Growth

4.4 Europe Biosimilar Insulin Sales Growth

4.5 Middle East & Africa Biosimilar Insulin Sales Growth

5 Americas

5.1 Americas Biosimilar Insulin Sales by Country

5.1.1 Americas Biosimilar Insulin Sales by Country (2016-2021)

5.1.2 Americas Biosimilar Insulin Revenue by Country (2016-2021)

5.2 Americas Biosimilar Insulin Sales by Type

5.3 Americas Biosimilar Insulin Sales by Distribution Channel

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilar Insulin Sales by Region

6.1.1 APAC Biosimilar Insulin Sales by Region (2016-2021)

6.1.2 APAC Biosimilar Insulin Revenue by Region (2016-2021)

6.2 APAC Biosimilar Insulin Sales by Type

6.3 APAC Biosimilar Insulin Sales by Distribution Channel

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biosimilar Insulin by Country

7.1.1 Europe Biosimilar Insulin Sales by Country (2016-2021)

7.1.2 Europe Biosimilar Insulin Revenue by Country (2016-2021)

7.2 Europe Biosimilar Insulin Sales by Type

7.3 Europe Biosimilar Insulin Sales by Distribution Channel

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilar Insulin by Country

8.1.1 Middle East & Africa Biosimilar Insulin Sales by Country (2016-2021)

8.1.2 Middle East & Africa Biosimilar Insulin Revenue by Country (2016-2021)

8.2 Middle East & Africa Biosimilar Insulin Sales by Type

8.3 Middle East & Africa Biosimilar Insulin Sales by Distribution Channel

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Biosimilar Insulin Distributors

10.3 Biosimilar Insulin Customer

11 Global Biosimilar Insulin Market Forecast

11.1 Global Biosimilar Insulin Forecast by Region

11.1.1 Global Biosimilar Insulin Forecast by Regions (2021-2026)

11.2.2 Global Biosimilar Insulin Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Biosimilar Insulin Forecast by Type

11.7 Global Biosimilar Insulin Forecast by Distribution Channel

12 Key Players Analysis

12.1 Eli Lilly

12.1.1 Eli Lilly Company Information

12.1.2 Eli Lilly Biosimilar Insulin Product Offered

12.1.3 Eli Lilly Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Eli Lilly Main Business Overview

12.1.5 Eli Lilly Latest Developments

12.2 Sanofi

12.2.1 Sanofi Company Information

12.2.2 Sanofi Biosimilar Insulin Product Offered

12.2.3 Sanofi Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Sanofi Main Business Overview

12.2.5 Sanofi Latest Developments

12.3 Gan&Lee

12.3.1 Gan&Lee Company Information

12.3.2 Gan&Lee Biosimilar Insulin Product Offered

12.3.3 Gan&Lee Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Gan&Lee Main Business Overview

12.3.5 Gan&Lee Latest Developments

12.4 Tonghua Dongbao

12.4.1 Tonghua Dongbao Company Information

12.4.2 Tonghua Dongbao Biosimilar Insulin Product Offered

12.4.3 Tonghua Dongbao Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Tonghua Dongbao Main Business Overview

12.4.5 Tonghua Dongbao Latest Developments

12.5 United Laboratory

12.5.1 United Laboratory Company Information

12.5.2 United Laboratory Biosimilar Insulin Product Offered

12.5.3 United Laboratory Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 United Laboratory Main Business Overview

12.5.5 United Laboratory Latest Developments

12.6 Geropharm

12.6.1 Geropharm Company Information

12.6.2 Geropharm Biosimilar Insulin Product Offered

12.6.3 Geropharm Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Geropharm Main Business Overview

12.6.5 Geropharm Latest Developments

12.7 Biocon

12.7.1 Biocon Company Information

12.7.2 Biocon Biosimilar Insulin Product Offered

12.7.3 Biocon Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Biocon Main Business Overview

12.7.5 Biocon Latest Developments

12.8 Wockhardt

12.8.1 Wockhardt Company Information

12.8.2 Wockhardt Biosimilar Insulin Product Offered

12.8.3 Wockhardt Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Wockhardt Main Business Overview

12.8.5 Wockhardt Latest Developments

13 Research Findings and Conclusion

Table 1. Biosimilar Insulin Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Biosimilar Insulin Glargine

Table 3. Major Players of Biosimilar Insulin Lispro

Table 4. Major Players of Other

Table 5. Global Biosimilar Insulin Sales by Type (2016-2021) & (K Unit)

Table 6. Global Biosimilar Insulin Sales Market Share by Type (2016-2021)

Table 7. Global Biosimilar Insulin Revenue by Type (2016-2021) & ($ million)

Table 8. Global Biosimilar Insulin Revenue Market Share by Type (2016-2021)

Table 9. Global Biosimilar Insulin Sale Price by Type (2016-2021)

Table 10. Global Biosimilar Insulin Sales by Distribution Channel (2016-2021) & (K Unit)

Table 11. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Table 12. Global Biosimilar Insulin Value by Distribution Channel (2016-2021)

Table 13. Global Biosimilar Insulin Revenue Market Share by Distribution Channel (2016-2021)

Table 14. Global Biosimilar Insulin Sale Price by Distribution Channel (2016-2021)

Table 15. Global Biosimilar Insulin Sales by Company (2019-2021) & (K Unit)

Table 16. Global Biosimilar Insulin Sales Market Share by Company (2019-2021)

Table 17. Global Biosimilar Insulin Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Biosimilar Insulin Revenue Market Share by Company (2019-2021)

Table 19. Global Biosimilar Insulin Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Biosimilar Insulin Producing Area Distribution and Sales Area

Table 21. Players Biosimilar Insulin Products Offered

Table 22. Biosimilar Insulin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Biosimilar Insulin Sales by Region (2016-2021) (K Unit)

Table 26. Global Biosimilar Insulin Sales Market Share by Region (2016-2021)

Table 27. Global Biosimilar Insulin Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Biosimilar Insulin Revenue Market Share by Region (2016-2021)

Table 29. Americas Biosimilar Insulin Sales by Country (2016-2021) & (K Unit)

Table 30. Americas Biosimilar Insulin Sales Market Share by Country (2016-2021)

Table 31. Americas Biosimilar Insulin Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Biosimilar Insulin Revenue Market Share by Country (2016-2021)

Table 33. Americas Biosimilar Insulin Sales by Type (2016-2021) & (K Unit)

Table 34. Americas Biosimilar Insulin Sales Market Share by Type (2016-2021)

Table 35. Americas Biosimilar Insulin Sales by Distribution Channel (2016-2021) & (K Unit)

Table 36. Americas Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Table 37. APAC Biosimilar Insulin Sales by Region (2016-2021) & (K Unit)

Table 38. APAC Biosimilar Insulin Sales Market Share by Region (2016-2021)

Table 39. APAC Biosimilar Insulin Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Biosimilar Insulin Revenue Market Share by Region (2016-2021)

Table 41. APAC Biosimilar Insulin Sales by Type (2016-2021) & (K Unit)

Table 42. APAC Biosimilar Insulin Sales Market Share by Type (2016-2021)

Table 43. APAC Biosimilar Insulin Sales by Distribution Channel (2016-2021) & (K Unit)

Table 44. APAC Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Table 45. Europe Biosimilar Insulin Sales by Country (2016-2021) & (K Unit)

Table 46. Europe Biosimilar Insulin Sales Market Share by Country (2016-2021)

Table 47. Europe Biosimilar Insulin Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Biosimilar Insulin Revenue Market Share by Country (2016-2021)

Table 49. Europe Biosimilar Insulin Sales by Type (2016-2021) & (K Unit)

Table 50. Europe Biosimilar Insulin Sales Market Share by Type (2016-2021)

Table 51. Europe Biosimilar Insulin Sales by Distribution Channel (2016-2021) & (K Unit)

Table 52. Europe Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Table 53. Middle East & Africa Biosimilar Insulin Sales by Country (2016-2021) & (K Unit)

Table 54. Middle East & Africa Biosimilar Insulin Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Biosimilar Insulin Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Biosimilar Insulin Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Biosimilar Insulin Sales by Type (2016-2021) & (K Unit)

Table 58. Middle East & Africa Biosimilar Insulin Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Biosimilar Insulin Sales by Distribution Channel (2016-2021) & (K Unit)

Table 60. Middle East & Africa Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Table 61. Key and Potential Regions of Biosimilar Insulin

Table 62. Key Application and Potential Industries of Biosimilar Insulin

Table 63. Key Challenges of Biosimilar Insulin

Table 64. Key Trends of Biosimilar Insulin

Table 65. Biosimilar Insulin Distributors List

Table 66. Biosimilar Insulin Customer List

Table 67. Global Biosimilar Insulin Sales Forecast by Region (2021-2026) & (K Unit)

Table 68. Global Biosimilar Insulin Consumption Market Forecast by Region

Table 69. Global Biosimilar Insulin Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Biosimilar Insulin Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Biosimilar Insulin Sales Forecast by Country (2021-2026) & (K Unit)

Table 72. Americas Biosimilar Insulin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Biosimilar Insulin Sales Forecast by Region (2021-2026) & (K Unit)

Table 74. APAC Biosimilar Insulin Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Biosimilar Insulin Sales Forecast by Country (2021-2026) & (K Unit)

Table 76. Europe Biosimilar Insulin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Biosimilar Insulin Sales Forecast by Country (2021-2026) & (K Unit)

Table 78. Middle East & Africa Biosimilar Insulin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Biosimilar Insulin Sales Forecast by Type (2021-2026) & (K Unit)

Table 80. Global Biosimilar Insulin Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Biosimilar Insulin Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Biosimilar Insulin Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Biosimilar Insulin Sales Forecast by Distribution Channel (2021-2026) & (K Unit)

Table 84. Global Biosimilar Insulin Sales Market Share Forecast by Distribution Channel (2021-2026)

Table 85. Global Biosimilar Insulin Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions)

Table 86. Global Biosimilar Insulin Revenue Market Share Forecast by Distribution Channel (2021-2026)

Table 87. Eli Lilly Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 88. Eli Lilly Biosimilar Insulin Product Offered

Table 89. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Eli Lilly Main Business

Table 91. Eli Lilly Latest Developments

Table 92. Sanofi Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Biosimilar Insulin Product Offered

Table 94. Sanofi Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. Gan&Lee Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 98. Gan&Lee Biosimilar Insulin Product Offered

Table 99. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. Gan&Lee Main Business

Table 101. Gan&Lee Latest Developments

Table 102. Tonghua Dongbao Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 103. Tonghua Dongbao Biosimilar Insulin Product Offered

Table 104. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. Tonghua Dongbao Main Business

Table 106. Tonghua Dongbao Latest Developments

Table 107. United Laboratory Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 108. United Laboratory Biosimilar Insulin Product Offered

Table 109. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. United Laboratory Main Business

Table 111. United Laboratory Latest Developments

Table 112. Geropharm Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 113. Geropharm Biosimilar Insulin Product Offered

Table 114. Geropharm Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Geropharm Main Business

Table 116. Geropharm Latest Developments

Table 117. Biocon Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 118. Biocon Biosimilar Insulin Product Offered

Table 119. Biocon Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. Biocon Main Business

Table 121. Biocon Latest Developments

Table 122. Wockhardt Basic Information, Biosimilar Insulin Manufacturing Base, Sales Area and Its Competitors

Table 123. Wockhardt Biosimilar Insulin Product Offered

Table 124. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. Wockhardt Main Business

Table 126. Wockhardt Latest Developments

List of Figures

Figure 1. Picture of Biosimilar Insulin

Figure 2. Biosimilar Insulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilar Insulin Sales Growth Rate 2016-2026 (K Unit)

Figure 7. Global Biosimilar Insulin Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Biosimilar Insulin Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Biosimilar Insulin Glargine

Figure 10. Product Picture of Biosimilar Insulin Lispro

Figure 11. Product Picture of Other

Figure 12. Global Biosimilar Insulin Sales Market Share by Type in 2020

Figure 13. Global Biosimilar Insulin Revenue Market Share by Type (2016-2021)

Figure 14. Biosimilar Insulin Consumed in Hospital

Figure 15. Global Biosimilar Insulin Market: Hospital (2016-2021) & (K Unit)

Figure 16. Biosimilar Insulin Consumed in Retail Pharmacy

Figure 17. Global Biosimilar Insulin Market: Retail Pharmacy (2016-2021) & (K Unit)

Figure 18. Biosimilar Insulin Consumed in Others

Figure 19. Global Biosimilar Insulin Market: Others (2016-2021) & (K Unit)

Figure 20. Global Biosimilar Insulin Sales Market Share by Distribution Channel (2016-2021)

Figure 21. Global Biosimilar Insulin Revenue Market Share by Distribution Channel in 2020

Figure 22. Biosimilar Insulin Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Biosimilar Insulin Revenue Market Share by Company in 2020

Figure 24. Global Biosimilar Insulin Sales Market Share by Regions (2016-2021)

Figure 25. Global Biosimilar Insulin Revenue Market Share by Region in 2020

Figure 26. Americas Biosimilar Insulin Sales 2016-2021 (K Unit)

Figure 27. Americas Biosimilar Insulin Revenue 2016-2021 ($ Millions)

Figure 28. APAC Biosimilar Insulin Sales 2016-2021 (K Unit)

Figure 29. APAC Biosimilar Insulin Revenue 2016-2021 ($ Millions)

Figure 30. Europe Biosimilar Insulin Sales 2016-2021 (K Unit)

Figure 31. Europe Biosimilar Insulin Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Biosimilar Insulin Sales 2016-2021 (K Unit)

Figure 33. Middle East & Africa Biosimilar Insulin Revenue 2016-2021 ($ Millions)

Figure 34. Americas Biosimilar Insulin Sales Market Share by Country in 2020

Figure 35. Americas Biosimilar Insulin Revenue Market Share by Country in 2020

Figure 36. Americas Biosimilar Insulin Sales Market Share by Type in 2020

Figure 37. Americas Biosimilar Insulin Sales Market Share by Distribution Channel in 2020

Figure 38. United States Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Biosimilar Insulin Sales Market Share by Region in 2020

Figure 43. APAC Biosimilar Insulin Revenue Market Share by Regions in 2020

Figure 44. APAC Biosimilar Insulin Sales Market Share by Type in 2020

Figure 45. APAC Biosimilar Insulin Sales Market Share by Distribution Channel in 2020

Figure 46. China Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Biosimilar Insulin Sales Market Share by Country in 2020

Figure 53. Europe Biosimilar Insulin Revenue Market Share by Country in 2020

Figure 54. Europe Biosimilar Insulin Sales Market Share by Type in 2020

Figure 55. Europe Biosimilar Insulin Sales Market Share by Distribution Channel in 2020

Figure 56. Germany Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Biosimilar Insulin Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Biosimilar Insulin Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Biosimilar Insulin Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Biosimilar Insulin Sales Market Share by Distribution Channel in 2020

Figure 65. Egypt Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Biosimilar Insulin Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles